Professor Martin Cowie (Professor of Cardiology, Imperial College London [Royal Brompton Hospital], London, UK) joins touchCARDIO at the annual European Heart Rhythm 2019 congress in Lisbon to discuss the latest developments, controversies and advantages of remote cardiac monitoring.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Professor Martin Cowie has received consultancy and research support from Abbott, Boston Scientific and Medtronic.
1. Please outline the key benefits for patients and healthcare systems of implementing remote cardiac monitoring. (0:14)
2. What remote monitoring technologies are currently in use? (1:10)
3. Are certain conditions particularly suited to remote monitoring? (2:28)
4. How does available evidence support the implementation or increased use of remote monitoring? (0:14)
5. What can be done to strengthen the case for adoption of remote cardiac monitoring, and increase the number of facilities using it? (1:30)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
Zsolt Piroth, TCT 2022: The value of post-PCI FFR and intravascular imaging for cardiovascular failure, a FAME 3 substudy
This FAME 3 substudy aimed to define the value of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and intravascular imaging for cardiovascular failure. In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the substudy of the FAME 3 trial and the implications for clinical practice. […]
Zsolt Piroth, TCT 2022: The value of measuring post-PCI FFR in patients with coronary artery disease
The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the prognostic value for measuring post-PCI FFR and intravascular imaging in CAD. Click here for part […]
Divaka Perera, ESC 2022: Percutaneous revascularisation in patients with severe ischaemic cardiomyopathy, the REVIVED trial
The REVIVED study aimed to assess whether the addition of stents when treating patients with severe ischaemic cardiomyopathy would be beneficial to patient outcomes. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the REVIVED trial, its outcomes and how they will affect the current treatment paradigm. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!